Genetic susceptibility to visceral leishmaniasis in The Sudan: Linkage and association with IL4 and IFNGR1

Genes and Immunity

Volumn 4, Issue 5, 2003, Pages 351-355

  Mohamed, H S ^a,b   Ibrahim, M E ^a   Miller, E N ^b   Peacock, C S ^b   Khalil, E A G ^a   Cordell, H J ^b   Howson, J M M ^b   El Hassan, A M ^a   Bereir, R E H ^a   Blackwell, Jennie M ^b  

^a UNIVERSITY OF KHARTOUM   (Sudan)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Association; IFNGR1; IL4; Leishmaniasis; Linkage

Indexed keywords

CYTOKINE; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 9; INTERFERON RECEPTOR;

ALLELE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ETHNIC DIFFERENCE; FAMILY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; INCIDENCE; LEISHMANIA DONOVANI; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NONPARAMETRIC TEST; PHENOTYPE; PRIORITY JOURNAL; SKIN LEISHMANIASIS; STATISTICAL SIGNIFICANCE; SUDAN; VISCERAL LEISHMANIASIS; ANALYSIS OF VARIANCE; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; STATISTICAL MODEL;

LEISHMANIA DONOVANI; NASO HEXACANTHUS;

ALLELES; ANALYSIS OF VARIANCE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-4; LEISHMANIASIS, VISCERAL; LIKELIHOOD FUNCTIONS; LINKAGE (GENETICS); LOGISTIC MODELS; POLYMORPHISM, GENETIC; RECEPTORS, INTERFERON; SUDAN;

EID: 1542327983     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363977     Document Type: Article

References (21)

1. Zijlstra EE, El Hassan AM, Ismael A, Ghalib HW. Endemic kala-azar in Eastern Sudan, a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis. Am J Trop Med Hyg 1994; 51: 826-836.
2. Kemp M, Kurtzhals JAL, Bendtzen K et al. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun 1993; 61: 1069-1073.
3. Kemp K, Kemp M, Kharazmi A et al. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis. Clin Exp Immunol 1999; 116: 500-504.
4. Kharazmi A, Kemp K, Ismail A et al. T-cell response in human leishmaniasis. Immunol Lett 1999; 65: 105-108.
5. Kurtzhals JA, Kemp M, Poulsen LK, Hansen MB, Kharazmi A, Theander TG. Interleukin-4 and interferon-gamma production by Leishmania stimulated peripheral blood mononuclear cells from nonexposed individuals. Scand J Immunol 1995; 41: 343-349.
6. Cordell HJ, Clayton DG. A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: application to HLA in type 1 diabetes. Am J Hum Genet 2002; 70: 124-141.
7. Zwingenberger K, Harms G, Pedrosa C, Omena S, Sandkamp B, Neifer S. Determinants of the immune response in visceral leishmaniasis: evidence for predominance of endogenous interleukin 4 over interferon-gamma production. Clin Immunol Immunopathol 1990; 57: 242-249.
8. Sundar S, Reed SG, Sharma S, Mehrotra A, Murray HW. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis. Am J Trop Med Hyg 1997; 56: 522-525.
9. Gessner A, Blum H, Rollinghoff M. Differential regulation of IL-9-expression after infection with Leishmania major in susceptible and resistant mice. Immunobiology 1993; 189: 419-435.
10. Roberts M, Mock BA, Blackwell JM. Mapping of genes controlling Leishmania major infection in CXS recombinant inbred mice. Eur J Immunogenet 1993; 20: 349-362.
11. Mock BA, Krall M, Kozak CA et al. IL9 maps to mouse chromosome 13 and human chromosome 5. Immunogenetics 1990; 31: 265-270.
12. Matthews DJ, Emson CL, McKenzie GJ, Jolin HE, Blackwell JM, McKenzie AN. IL-13 is a susceptibility factor for Leishmania major infection. J Immunol 2000; 164: 1458-1462.
13. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 26: 1941-1949.
14. Belkaid Y, Hoffmann KF, Mendez S et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med 2001; 194: 1497-1506.
15. Zijlstra EE, El-Hassan AM. Leishmaniasis in Sudan. 4. Post kala-azar dermal leishmaniasis. Trans R Soc Trop Med Hyg 2001; 95: S1/59-S1/76.
16. Musa AM, Khalil EAG, Rahemm MA et al. Natural history of Sudanese post Kala-azar demal leishmaniasis: clinical immunological and prognostic features. Trans R Soc Trop Med Hyg 2003; in press.
17. Mout R, Willemze R, Landegent JE. Repeat polymorphisms in the interleukin-4 gene (IL4). Nucleic Acids Res 1991; 19: 3763.
18. Polymeropoulos MH, Xiao H, Rath DS, Merril CR. Dinucleotide repeat polymorphism at the human interleukin 9 gene. Nucleic Acids Res 1991; 19: 688.
19. Altare F, Jouanguy E, Lamhamedi-Cherradi S et al. A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFNgamma in a compound heterozygous child. Am J Hum Genet 1998; 62: 723-726.
20. Gudbjartsson DF, Jonasson K, Frigge ML, Kong A. Allegro, a new computer program for multipoint linkage analysis. Nat Genet 2000; 25: 12-13.
21. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-516.